作者: Ahmad Movahedpour , Nahid Ahmadi , Younes Ghasemi , Amir Savardashtaki , Zahra Shabaninejad
DOI: 10.1002/JCB.29053
关键词:
摘要: Prostate cancer (PCa) is one of the most common malignancies among men. Despite advancement in technology and medicine over past decades, late diagnosis remains a critical milestone effective treatment. Therefore, it necessary to identify novel reliable biomarkers which are specifically sensitive specific for prognosis prediction clinical outcomes. MicroRNAs (miRNAs) play important roles posttranslational regulations genes. Circulating exosomal miRNAs can be applied as useful diagnostic markers different type malignancies, including PCa. Herein, we summarized various (diagnostic, therapeutic, prognostic) Moreover, highlighted new candidate monitoring response therapy patients with